Cooley represented Nuvation Bio in the transaction, and Sidley Austin represented Sagard Healthcare Partners. Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the...
You must be a Standard 1 Year member to access this content.
Cooley advised Thirty Madison on the deal. Thirty Madison announced that it will ensure continued care for over a hundred thousand patients after strategically acquiring assets,...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Blueprint Medicines Corporation on the deal while Cooley represented Sixth Street. Blueprint Medicines Corporation (NASDAQ: BPMC) announced its strategic financing collaborations with Sixth...
You must be a Standard 1 Year member to access this content.
Mayer Brown represented Alpargatas S.A. in the transaction while Cooley advised Rothy. Alpargatas S.A., a Brazil-based, global footwear company creator of the famous flip flop “Havaianas,”...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz represented IAC, while Cooley represented Meredith in the transaction. IAC (NASDAQ: IAC) and Meredith Corporation (NYSE: MDP), a leading media company...
You must be a Standard 1 Year member to access this content.
